The short version
LillyDirect (Zepbound vials) is a manufacturer direct-to-patient channel for the FDA-approved product. As of the August 25, 2026 build, for tirzepatide its lowest 12-month all-in total is $4,938 (month-to-month plan, verified), shown as a brand benchmark rather than ranked against compounded telehealth plans. Verification status: verified.
The numbers, plan by plan
- Tirzepatide (brand, vial, month-to-month plan): $299 per month, rising to $449 per month at the highest published dose. Status: verified, checked August 25, 2026. Self-pay Zepbound vials: $299 at 2.5 mg (initiation dose), $399 at 5 mg, $449 at 7.5 to 15 mg under the Self Pay Journey offer when refill-timing requirements are met; regular prices if conditions are missed are $499 at 7.5 mg and $699 at 10, 12.5 and 15 mg. Card terms stated through December 31, 2026.
Fees and what the price includes
The published price includes the medication and clinical care and shipping, with no separate membership fee. Shipping is included. A consultation fee is billed separately. The medication price rises with dose, so our 12-month total uses the titration model described on the methodology page.
How this pricing structure plays out over a year
Because the price rises with dose, roughly nine of the first twelve months are billed at the higher tier on the label's schedule, and every month after that.
Compared with the field
On tirzepatide, LillyDirect (Zepbound vials)'s lowest twelve-month total of $4,938 is $3,438 above the lowest (Trimi, $1,500) and above the median of $3,090 across 30 ranked providers. On the value score it scores 47 against 92 for NexLife, the best-scoring provider; the gap comes from cost, transparency, flexibility, care.
Pharmacy, coverage and cancellation
The provider reports serving all fifty states. Dispensing: brand. Named pharmacies: Lilly-contracted mail-order pharmacy. Commitment: month-to-month. Cancellation: No subscription; order per fill.
Questions to ask LillyDirect (Zepbound vials) before paying
Ask, in writing: Will my dosing instructions state the concentration of the vial you actually ship, and will you reissue them if it changes? A provider that answers all of these promptly is operating in the open; one that will not name its pharmacy has answered the most important question.
What works
FDA-approved tirzepatide with manufacturer quality control. No membership; pay per fill. Manufacturer prices fell substantially in late 2025.
What to weigh against it
Self-pay prices remain two to three times compounded prices at maintenance doses. Vials require drawing up doses with a syringe rather than using a pen. Prescription and clinical care must be arranged separately.
Who should choose LillyDirect (Zepbound vials)
Patients who want FDA-approved tirzepatide and can afford manufacturer self-pay pricing. A patient with insurance coverage for Zepbound or Wegovy should compare the copay route first; a patient who wants a verified flat all-in price with month-to-month flexibility should compare the best overall provider on our value score; and any patient should ask which pharmacy fills the prescription before paying.
How we verified this
Lilly's coverage and savings page verifies the self-pay vial tiers ($299 at 2.5 mg, $399 at 5 mg, $449 at 7.5–15 mg under conditions, with $499/$699 regular prices) and states the program terms through December 31, 2026. Verified against the provider's own pages on 2026-08-25 (first-party verification pass).